26m
A Look At Denali Therapeutics (DNLI) Valuation As New ETV Rare Disease Data Presentations Approach
Denali Therapeutics (DNLI) is back in focus after detailing plans to showcase new clinical and preclinical data from its Enzyme Transport Vehicle programs at the WORLDSymposium, alongside a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results